SN-38, like camptothecin and its derivatives, is an inhibitor of DNA topoisomerase I (Top1), a nuclear enzyme involved in DNA replication and transcription highly expressed in cancer tissues, forming a stable drug–enzyme–DNA ternary complex that hinders DNA replication, ultimately resulting in apoptosis and cell death [133]. This evidence concerns the gene TOP1 and cancer.